Skip to main content

Table 1 Demographic data of the 73 CRC patients

From: A reappraisal of lymph node dissection in colorectal cancer during primary surgical resection

Variables

Mean ± SD/number (%)

Gender

 

 Female/Male

30 (41.1)/43 (58.9)

Age (years)

65.3 ± 11.2

Tumor location

 

 Cecum

4 (5.5)

 Ascending colon

13 (17.8)

 Transverse colon

15 (20.5)

 Descending colon

6 (8.2)

 Sigmoid colon

19 (26.0)

 Rectum

16 (21.9)

Type of surgical resection

 

 Segmental resection

4 (5.5)

 Right hemicolectomy

25 (34.2)

 Left hemicolectomy

6 (8.2)

 Anterior resection

9 (12.3)

 Lower anterior resection

22 (30.1)

 Sub-total colectomy

2 (2.7)

 Abdominal-perineal resection

2 (2.7)

 Hartmann’s procedure

3 (4.1)

Tumor configuration

 

 Exophytic/ulcerative

25 (34.2)/48 (65.8)

Pathological findings

 

T/N/M status and cancer stage, AJCC8th

 

T-status

 

 T1/T2/T3/T4

4 (5.5)/9 (12.3)/56 (76.7)/4 (5.5)

N-status

 

 N0/N1/N2

31 (42.5)/17 (23.3)/25 (34.2)

M-status

 

 M0/M1

67 (91.8)/6 (8.2)

Stage

 

 I/II/III/IV

12 (16.4)/19 (26.0)/36 (49.3)/6 (8.2)

Maximal tumor diameter (cm)

5.1 ± 2.6

Lymphatic vessel invasion

 

 No/yes/not analyzed

42 (57.5)/22 (30.1)/9 (12.3)

Venous vessel invasion

 

 No/yes/not analyzed

52 (71.2)/11 (15.1)/10 (13.7)

Perineural invasion

 

 No/yes/not analyzed

53 (72.6)/4 (5.5)/16 (21.9)

Histological grade

 Low/intermediate/high grade

51 (69.9)/16 (21.9)/6 (8.2)

No. of TDLNs (25, 50, and 75 percentile)

20.7 ± 11.8 (10, 19, and 28.5)

No. of PDLNs (25, 50, and 75 percentile)

3.6 ± 5.2 (0, 1 and 5)

Positive rate

18.1 ± 23.6

No. of NDLNs (25, 50, and 75 percentile)

17.2 ± 11.2 (9, 15, and 26.5)

Follow-up period (mean, 95%CI) (months)

70.0 (59.5–80.5)

Overall survival (mean, 95%CI) (months)

91.6 (78.6–105.5)

  1. CRC colorectal cancer, No. number, TDLNs total dissected lymph nodes, PDLNs positive dissected lymph nodes, NDLNs negative dissected lymph nodes, Positive rate No. PDLNs/No. TDLNs, %, SD standard deviation